68071-1895 NDC - ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)

Drug Information

Product NDC: 68071-1895

Proprietary Name: ZOLPIDEM TARTRATE

Non Proprietary Name: zolpidem tartrate

Active Ingredient(s):
  • 5 mg/1 ZOLPIDEM TARTRATE


Administration Route(s): ORAL

Dosage Form(s): TABLET

Pharmacy Class(es):
  • gamma-Aminobutyric Acid-ergic Agonist [EPC];
  • GABA A Agonists [MoA];
  • Pyridines [CS];
  • Central Nervous System Depression [PE]

Labeler Information

Labeler Name: NuCare Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077903
Marketing Category: ANDA
Start Marketing Date:9/5/2007

Package Information

No. Package Code Package Description Billing Unit
168071-1895-330 TABLET in 1 BOTTLE (68071-1895-3)
268071-1895-414 TABLET in 1 BOTTLE (68071-1895-4)
368071-1895-545 TABLET in 1 BOTTLE (68071-1895-5)

NDC Record

Field Name Field Value Definition
PRODUCT NDC68071-1895The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEZOLPIDEM TARTRATEThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEzolpidem tartrateThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLETThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/5/2007This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA077903This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMENuCare Pharmaceuticals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEZOLPIDEM TARTRATEThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH5 
ACTIVE INGRED UNITmg/1 
PHARM CLASSESgamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [CS],Central Nervous System Depression [PE] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 7/15/2019